11.57
price up icon4.72%   0.51
 
loading
Precedente Chiudi:
$11.06
Aprire:
$11.14
Volume 24 ore:
641.72K
Relative Volume:
0.33
Capitalizzazione di mercato:
$785.41M
Reddito:
$65,400
Utile/perdita netta:
$-46.34M
Rapporto P/E:
-12.58
EPS:
-0.92
Flusso di cassa netto:
$-38.74M
1 W Prestazione:
+4.06%
1M Prestazione:
-30.06%
6M Prestazione:
-5.84%
1 anno Prestazione:
+139.80%
Intervallo 1D:
Value
$11.05
$11.87
Intervallo di 1 settimana:
Value
$10.70
$11.87
Portata 52W:
Value
$3.61
$17.43

CorMedix Inc Stock (CRMD) Company Profile

Name
Nome
CorMedix Inc
Name
Telefono
908-517-9500
Name
Indirizzo
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
Dipendente
14
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
CRMD's Discussions on Twitter

Confronta CRMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRMD
CorMedix Inc
11.58 846.26M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.10 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.53 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.56 29.19B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-30 Downgrade D. Boral Capital Buy → Hold
2025-06-30 Iniziato H.C. Wainwright Buy
2025-03-07 Iniziato Leerink Partners Outperform
2025-01-13 Iniziato D. Boral Capital Buy
2024-08-26 Iniziato Rodman & Renshaw Buy
2023-08-10 Iniziato RBC Capital Mkts Outperform
2021-02-17 Iniziato Needham Buy
2020-09-29 Iniziato JMP Securities Mkt Outperform
2020-09-21 Iniziato Truist Buy
2019-12-18 Iniziato B. Riley FBR Buy
2019-03-26 Reiterato H.C. Wainwright Buy
2018-12-06 Iniziato ROTH Capital Buy
2017-09-25 Reiterato H.C. Wainwright Buy
2017-08-10 Reiterato Rodman & Renshaw Buy
2017-05-05 Reiterato Rodman & Renshaw Buy
2016-11-11 Reiterato FBR & Co. Outperform
2016-03-17 Reiterato FBR Capital Outperform
2016-03-03 Iniziato FBR Capital Outperform
2015-11-16 Reiterato ROTH Capital Neutral
2015-10-29 Reiterato ROTH Capital Neutral
2015-05-06 Downgrade ROTH Capital Buy → Neutral
2014-12-08 Reiterato ROTH Capital Buy
2011-10-03 Downgrade Maxim Group Buy → Hold
Mostra tutto

CorMedix Inc Borsa (CRMD) Ultime notizie

pulisher
09:29 AM

CorMedix Inc. Stock Analysis and ForecastFree Stock Market Beginners Guide - Autocar Professional

09:29 AM
pulisher
03:59 AM

What drives CorMedix Inc. stock priceExceptional ROI - Autocar Professional

03:59 AM
pulisher
Jul 22, 2025

What analysts say about CorMedix Inc. stockMassive portfolio appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is CorMedix Inc. a good long term investmentUnmatched market performance - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

CorMedix Inc. (CRMD) Plunges 1.90% to 2025 Low - AInvest

Jul 18, 2025
pulisher
Jul 15, 2025

Why CorMedix Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes CorMedix Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How CorMedix Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

CorMedix soars on increased Q2 sales guidance - MSN

Jul 14, 2025
pulisher
Jul 14, 2025

Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive? - Yahoo Finance

Jul 14, 2025
pulisher
Jul 12, 2025

CorMedix’s DEFENCATH® Study: A Potential Game-Changer in Infection Prevention - MSN

Jul 12, 2025
pulisher
Jul 11, 2025

CorMedix Inc. Advances Pediatric Dialysis Safety with New Clinical Study - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

(CRMD) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire

Jul 10, 2025
pulisher
Jul 07, 2025

RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18 - 富途牛牛

Jul 07, 2025
pulisher
Jul 02, 2025

Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. (NASDAQ: CRMD); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on - GlobeNewswire

Jul 02, 2025
pulisher
Jul 02, 2025

Important Notice to Long-Term Shareholders of AdaptHealth Corp. (NASDAQ: AHCO); CorMedix Inc. ... - Bluefield Daily Telegraph

Jul 02, 2025
pulisher
Jul 01, 2025

CorMedix Completes $82.2 Million Stock Offering - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

CorMedix stock rating downgraded to Hold from Buy by D. Boral Capital - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

CorMedix stock rating reiterated as Buy by H.C. Wainwright - Investing.com India

Jun 30, 2025
pulisher
Jun 27, 2025

CorMedix slides after pricing $85M stock offering - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

CorMedix prices $85 million public offering of common stock By Investing.com - Investing.com South Africa

Jun 27, 2025
pulisher
Jun 27, 2025

CorMedix Stock Tumbles After $85M Stock Sale; But Retail Sees Bargain In DefenCath Bet - Asianet Newsable

Jun 27, 2025
pulisher
Jun 26, 2025

CorMedix plans $85 million common stock offering - Investing.com India

Jun 26, 2025
pulisher
Jun 26, 2025

CorMedix stock falls after $85 million share offering announcement - Investing.com

Jun 26, 2025
pulisher
Jun 26, 2025

CorMedix stock falls after $85 million share offering announcement By Investing.com - Investing.com UK

Jun 26, 2025
pulisher
Jun 25, 2025

CorMedix shareholders approve board nominees and key proposals at annual meeting - Investing.com

Jun 25, 2025
pulisher
Jun 24, 2025

CorMedix stock rises as Truist reiterates buy on expanded DefenCath rollout - Investing.com Canada

Jun 24, 2025
pulisher
Jun 23, 2025

CorMedix Lifts Q2 Outlook As Dialysis Partner Expands DefenCath Use; Needham Raises PT To $20 - Stocktwits

Jun 23, 2025
pulisher
Jun 23, 2025

CorMedix inc. Announces Customer Implementation - The Manila Times

Jun 23, 2025
pulisher
Jun 23, 2025

CorMedix (CRMD) Target Price Increased by Needham Following Positive Update | CRMD Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 21, 2025

Cormedix (CRMD) Receives a Rating Update from a Top Analyst - The Globe and Mail

Jun 21, 2025
pulisher
Jun 20, 2025

CorMedix price target raised to $17 from $13 at RBC Capital - TipRanks

Jun 20, 2025
pulisher
Jun 20, 2025

Learn to Evaluate (CRMD) using the Charts - news.stocktradersdaily.com

Jun 20, 2025
pulisher
Jun 20, 2025

CorMedix stock price target raised to $17 from $13 at RBC Capital - Investing.com

Jun 20, 2025
pulisher
Jun 19, 2025

CorMedix Inc.'s (NASDAQ:CRMD) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance

Jun 19, 2025
pulisher
Jun 18, 2025

Despite shrinking by US$64m in the past week, CorMedix (NASDAQ:CRMD) shareholders are still up 366% over 3 years - simplywall.st

Jun 18, 2025
pulisher
Jun 13, 2025

CorMedix stock rises after earnings, revenue beat - MSN

Jun 13, 2025
pulisher
Jun 11, 2025

CorMedix stock soars to 52-week high, hits $15.33 By Investing.com - Investing.com South Africa

Jun 11, 2025

CorMedix Inc Azioni (CRMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.82
price up icon 4.66%
$35.94
price down icon 0.41%
$102.81
price down icon 0.07%
$27.66
price up icon 4.37%
$113.20
price up icon 1.57%
biotechnology ONC
$295.56
price down icon 0.03%
Capitalizzazione:     |  Volume (24 ore):